These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 6433045

  • 1. Mitomycin C reused: an in vitro cost-effectiveness study.
    Carroll PR, Williams RD, Kim MJ, Dombrovskis S.
    J Urol; 1984 Sep; 132(3):583-6. PubMed ID: 6433045
    [Abstract] [Full Text] [Related]

  • 2. Treatment of superficial bladder cancer with intravesical mitomycin C: analysis of immediate and long-term response in 70 patients.
    Soloway MS.
    J Urol; 1985 Dec; 134(6):1107-9. PubMed ID: 3932684
    [Abstract] [Full Text] [Related]

  • 3. Studies of mitomycin C absorption after intravesical treatment of superficial bladder tumors.
    Wajsman Z, Dhafir RA, Pfeffer M, MacDonald S, Block A, Dragone N, Pontes JE.
    J Urol; 1984 Jul; 132(1):30-3. PubMed ID: 6427484
    [Abstract] [Full Text] [Related]

  • 4. Intravesical thiotepa and mitomycin C treatment immediately after transurethral resection and later for superficial (stages Ta and Tis) bladder cancer: a prospective, randomized, stratified study with crossover design.
    Zincke H, Benson RC, Hilton JF, Taylor WF.
    J Urol; 1985 Dec; 134(6):1110-4. PubMed ID: 3932685
    [Abstract] [Full Text] [Related]

  • 5. The stability and antitumor activity of recycled (intravesical) mitomycin C.
    Hopkins SC, Buice RG, Matheny R, Soloway MS.
    Cancer; 1984 May 15; 53(10):2063-8. PubMed ID: 6423261
    [Abstract] [Full Text] [Related]

  • 6. Severe bladder contracture in patient receiving intravesical mitomycin C for superficial bladder cancer.
    Baker WC, Russo MA, deVere White RW.
    Urology; 1987 Oct 15; 30(4):357-8. PubMed ID: 3116739
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Intravesical mitomycin C for superficial transitional cell carcinoma.
    Bolenz C, Cao Y, Arancibia MF, Trojan L, Alken P, Michel MS.
    Expert Rev Anticancer Ther; 2006 Aug 15; 6(8):1273-82. PubMed ID: 16925493
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Long-term mitomycin C instillation after transurethral resection of superficial bladder carcinoma: influence on recurrence, progression and survival.
    Huland H, Otto U, Droese M, Klöppel G.
    J Urol; 1984 Jul 15; 132(1):27-9. PubMed ID: 6427483
    [Abstract] [Full Text] [Related]

  • 13. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
    Witjes WP, Witjes JA, Oosterhof GO, Debruyne MJ.
    Semin Urol Oncol; 1996 Feb 15; 14(1 Suppl 1):10-6. PubMed ID: 8727805
    [Abstract] [Full Text] [Related]

  • 14. Intravesical mitomycin C therapy for superficial bladder cancer. Report of a multicentre phase II study.
    MacFarlane JR, Tolley DA.
    Br J Urol; 1985 Feb 15; 57(1):37-9. PubMed ID: 3918605
    [Abstract] [Full Text] [Related]

  • 15. Intravesical chemotherapy: studies on the relationship between osmolality and cytotoxicity.
    Groos E, Masters JR.
    J Urol; 1986 Aug 15; 136(2):399-402. PubMed ID: 3090275
    [Abstract] [Full Text] [Related]

  • 16. Chemotherapy for bladder cancer.
    Whitmore WF.
    J Urol; 1985 Dec 15; 134(6):1181-2. PubMed ID: 3932688
    [No Abstract] [Full Text] [Related]

  • 17. Treatment schedule of intravesical chemotherapy with mitomycin C in superficial bladder cancer: short-term courses or maintenance therapy.
    van der Meijden AP, DeBruyne FM.
    Urology; 1988 Mar 15; 31(3 Suppl):26-9. PubMed ID: 3126592
    [Abstract] [Full Text] [Related]

  • 18. Choosing the right intravesical chemotherapeutic agent. Results of an in vitro monolayer cell culture assay.
    Whelan P, Flynn C, Ramsden C.
    Br J Urol; 1984 Dec 15; 56(6):655-7. PubMed ID: 6442872
    [Abstract] [Full Text] [Related]

  • 19. Intravesical chemotherapy. Studies on the relationship between pH and cytotoxicity.
    Groos E, Walker L, Masters JR.
    Cancer; 1986 Sep 15; 58(6):1199-203. PubMed ID: 3091241
    [Abstract] [Full Text] [Related]

  • 20. [Blood and tissue levels of mitomycin C after intravesical instillation].
    Flüchter SH, Hlobil H, Harzmann R, Rothe KF, Bichler KH.
    Urol Int; 1983 Sep 15; 38(6):321-8. PubMed ID: 6419427
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.